chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Eosinophil count decreased, Eosinophil percentage decreased, Erythema
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Fraction of inspired oxygen, Glomerular filtration rate decreased, Glucose tolerance test, Glucose urine absent, Granulocyte count
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Granulocyte percentage, Haematocrit decreased, Haemoglobin decreased, Hypotension, Intensive care
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: International normalised ratio normal, Lymphocyte count decreased, Lymphocyte percentage decreased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin decreased
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Mean cell volume normal, Mean platelet volume normal, Monocyte count, Monocyte percentage, Myocardial ischaemia
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Nasal cavity cancer, Nitrite urine absent, PCO2 decreased, PO2 decreased, Pain
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Pallor, Peripheral swelling, Platelet count normal, Pneumonia, Positive end-expiratory pressure
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Protein total normal, Protein urine, Prothrombin time prolonged, Red blood cell count normal, Red blood cells urine positive
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Red cell distribution width increased, Respiratory alkalosis, SARS-CoV-2 test positive, Sepsis, Septic embolus
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Skin warm, Specific gravity urine normal, Staphylococcal bacteraemia, Swelling, Tachypnoea
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin I increased, Urinary tract infection, Urine abnormality, Urine ketone body absent, Urine leukocyte esterase positive
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Urobilinogen urine, White blood cell count increased, White blood cells urine positive, pH urine normal
Clinical narrative: Narrative: 8/21/2022 - Pt presented to ED with Bilateral lower extremities swollen. Left appears blue and pale - pulse present. Right lower extremities red / swollen / hot. Complains of SOB at rest, loose stools, cough, decreased appetite, and swelling all over especially bilateral legs x 1 week, left leg appears pale and blue / right leg appears red / warm / swollen. Covid positive at home according to patient. Patient complains of all over body aches. Patient states he has nose CA - Nose appears blue in color. Patient placed on cotninous bp pressure / pulse ox / cardiac monitoring. Respirations remain tachypneic ~28-30 with sats 94% on 4 l/nc. Pt to be admitted to SDU. Primary Diagnosis: Severe sepsis. community acquired pneumonia. Covid 19. UTI. right lower extremity cellulitis, respiratory alkalosis. demand ischemia troponemia. acute renal insufficiency. Patient is a 57 yo gentleman with RA on etanercept and prednisone, admitted the SDU on 8/21/22 with sepsis & acute hypoxic respiratory failure due to COVID, RLE cellulitis and UTI, and started on empiric cefepime and vancomycin. On 8/22/22, patient developed new onset aflutter with RVR, hypotension, worsening hypoxic respiratory failure requiring HFNC. The patient was transferred to MICU, he was started on an amiodarone gtt. Chest CTA showed evidence of bilateral PE/septic emboli and started on lovenox. The patient has persistent MRSA bacteremia, no evidence of vegetations on TTE. Pt transferred to the SDU this morning. PT treated with decadron and remdesivir.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered, Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Narrative: Pt had erythematous, warm, swollen softball size area at the injection site. She was instructed to take OTC Benadryl and use heat packs for relief. Pt was also instructed not to receive any more COVID vaccines.
Age: 73.0
Sex: M
Vaccine: PNC13
Symptoms: Body temperature increased, Diarrhoea, Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Narrative: 6/18/2022 - Pt's sibling called advice line with following complaint: Patient's sister called with concern of low grade temp today and temp of 101.2 this evening and she gave him Tylenol. She reports a rash to his right hip. Sister denies any cough in patient. Triage completed and advised to clinic within 12-24 hours. Sister encouraged EMS due to patient immobility from CVA last year. She states she will monitor the patient if the temperature goes back up she will call EMS. Patient is nonverbal and bed bound. Sister states he had 3-4 episodes of diarrhea today ,which she states is his baseline daily. 6/21/22 Nutrition note - Home visit with patient and sister. Patient was seen sitting up in hospital bed sleeping. Sister feels patient had a reaction to the PNA vaccine last week with fever and diarrhea. She spoke with NP during visit. His appetite was not affected and continues to take adequate fluids. Sister reports loose stools improved somewhat with Metamucil until possible reaction to PNA vaccine. 6/21/2022 Nurse Pract. Note: Sister reports that pt received pneumonia Vaccine last week. She states that on Friday she noted that pt started to have low grade fever. She reports on Saturday she noted that injection site was red, warm to the touch and there was a red rash that was spreading. Pt also began having fever of 101 and diarrhea. She reports she contact the advice line at that point (6/18/22). She did not take patient to ED. She gave him Tylenol and monitored rash. Pt still having some diarrhea but rash is starting to resolve. . Denies dyspnea or facial edema.
Age: 73.0
Sex: M
Vaccine: PNC13
Symptoms: Pyrexia, Rash
Clinical narrative: Narrative: 6/18/2022 - Pt's sibling called advice line with following complaint: Patient's sister called with concern of low grade temp today and temp of 101.2 this evening and she gave him Tylenol. She reports a rash to his right hip. Sister denies any cough in patient. Triage completed and advised to clinic within 12-24 hours. Sister encouraged EMS due to patient immobility from CVA last year. She states she will monitor the patient if the temperature goes back up she will call EMS. Patient is nonverbal and bed bound. Sister states he had 3-4 episodes of diarrhea today ,which she states is his baseline daily. 6/21/22 Nutrition note - Home visit with patient and sister. Patient was seen sitting up in hospital bed sleeping. Sister feels patient had a reaction to the PNA vaccine last week with fever and diarrhea. She spoke with NP during visit. His appetite was not affected and continues to take adequate fluids. Sister reports loose stools improved somewhat with Metamucil until possible reaction to PNA vaccine. 6/21/2022 Nurse Pract. Note: Sister reports that pt received pneumonia Vaccine last week. She states that on Friday she noted that pt started to have low grade fever. She reports on Saturday she noted that injection site was red, warm to the touch and there was a red rash that was spreading. Pt also began having fever of 101 and diarrhea. She reports she contact the advice line at that point (6/18/22). She did not take patient to ED. She gave him Tylenol and monitored rash. Pt still having some diarrhea but rash is starting to resolve. . Denies dyspnea or facial edema.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Benign prostatic hyperplasia, COVID-19, Cardiac failure congestive, Chest X-ray abnormal
Clinical narrative: Narrative:  Pt presented to facility ER 8/22/2022. HPI: Patient presenting to the ER for evaluation of weakness. Patient states over the last year or so after dialysis he feels very weak. Patient feels very fatigued with no energy and sleeps most of the day. Patient states he has chronic short of breath but no acute on chronic shortness of breath or chest pain. Patient denies any nausea vomiting fever chills or abdominal pain. Patient states he has had a cough for the last couple days and wheezing started last night where he used a breathing treatment. Patient states he did have Covid back in April 2021. Pt admitted 8/22/22 through 8/25/22 with principle diagnosis = mild COVID-19. ADDITIONAL DIAGNOSES: chronic obstructive pulmonary disease exacerbation coronary artery disease Chronic combined systolic and diastolic congestive heart failure end stage renal disease on hemodialysis benign prostatic hypertrophy chronic normocytic anemia diabetes mellitus type 2 HOSPITAL COURSE: Pt admitted to the floor. dx covid 19. cxr with persistent hazy density at the peripheral left lung base. pt started on cefepime and dexamethazone. unable to start remdesivir due to ESRD on HD. continued chronic medications. pt with some improvement in 24 hours. stopped antibiotics. changed from dexamethasone to prednisone. pt held overnight again due to significant wheezing. pt tolerating medications. no hypoxia noted. pt stable for d/c to home with prednisone.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic left ventricular failure, Chronic obstructive pulmonary disease, Coronary artery disease, Cough, Dialysis
Clinical narrative: Narrative:  Pt presented to facility ER 8/22/2022. HPI: Patient presenting to the ER for evaluation of weakness. Patient states over the last year or so after dialysis he feels very weak. Patient feels very fatigued with no energy and sleeps most of the day. Patient states he has chronic short of breath but no acute on chronic shortness of breath or chest pain. Patient denies any nausea vomiting fever chills or abdominal pain. Patient states he has had a cough for the last couple days and wheezing started last night where he used a breathing treatment. Patient states he did have Covid back in April 2021. Pt admitted 8/22/22 through 8/25/22 with principle diagnosis = mild COVID-19. ADDITIONAL DIAGNOSES: chronic obstructive pulmonary disease exacerbation coronary artery disease Chronic combined systolic and diastolic congestive heart failure end stage renal disease on hemodialysis benign prostatic hypertrophy chronic normocytic anemia diabetes mellitus type 2 HOSPITAL COURSE: Pt admitted to the floor. dx covid 19. cxr with persistent hazy density at the peripheral left lung base. pt started on cefepime and dexamethazone. unable to start remdesivir due to ESRD on HD. continued chronic medications. pt with some improvement in 24 hours. stopped antibiotics. changed from dexamethasone to prednisone. pt held overnight again due to significant wheezing. pt tolerating medications. no hypoxia noted. pt stable for d/c to home with prednisone.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, End stage renal disease, Fatigue, Haemodialysis, Hypersomnia
Clinical narrative: Narrative:  Pt presented to facility ER 8/22/2022. HPI: Patient presenting to the ER for evaluation of weakness. Patient states over the last year or so after dialysis he feels very weak. Patient feels very fatigued with no energy and sleeps most of the day. Patient states he has chronic short of breath but no acute on chronic shortness of breath or chest pain. Patient denies any nausea vomiting fever chills or abdominal pain. Patient states he has had a cough for the last couple days and wheezing started last night where he used a breathing treatment. Patient states he did have Covid back in April 2021. Pt admitted 8/22/22 through 8/25/22 with principle diagnosis = mild COVID-19. ADDITIONAL DIAGNOSES: chronic obstructive pulmonary disease exacerbation coronary artery disease Chronic combined systolic and diastolic congestive heart failure end stage renal disease on hemodialysis benign prostatic hypertrophy chronic normocytic anemia diabetes mellitus type 2 HOSPITAL COURSE: Pt admitted to the floor. dx covid 19. cxr with persistent hazy density at the peripheral left lung base. pt started on cefepime and dexamethazone. unable to start remdesivir due to ESRD on HD. continued chronic medications. pt with some improvement in 24 hours. stopped antibiotics. changed from dexamethasone to prednisone. pt held overnight again due to significant wheezing. pt tolerating medications. no hypoxia noted. pt stable for d/c to home with prednisone.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Normocytic anaemia, SARS-CoV-2 test positive, Type 2 diabetes mellitus, Wheezing
Clinical narrative: Narrative:  Pt presented to facility ER 8/22/2022. HPI: Patient presenting to the ER for evaluation of weakness. Patient states over the last year or so after dialysis he feels very weak. Patient feels very fatigued with no energy and sleeps most of the day. Patient states he has chronic short of breath but no acute on chronic shortness of breath or chest pain. Patient denies any nausea vomiting fever chills or abdominal pain. Patient states he has had a cough for the last couple days and wheezing started last night where he used a breathing treatment. Patient states he did have Covid back in April 2021. Pt admitted 8/22/22 through 8/25/22 with principle diagnosis = mild COVID-19. ADDITIONAL DIAGNOSES: chronic obstructive pulmonary disease exacerbation coronary artery disease Chronic combined systolic and diastolic congestive heart failure end stage renal disease on hemodialysis benign prostatic hypertrophy chronic normocytic anemia diabetes mellitus type 2 HOSPITAL COURSE: Pt admitted to the floor. dx covid 19. cxr with persistent hazy density at the peripheral left lung base. pt started on cefepime and dexamethazone. unable to start remdesivir due to ESRD on HD. continued chronic medications. pt with some improvement in 24 hours. stopped antibiotics. changed from dexamethasone to prednisone. pt held overnight again due to significant wheezing. pt tolerating medications. no hypoxia noted. pt stable for d/c to home with prednisone.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Rhinorrhoea
Clinical narrative: runny nose
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Cough, Fatigue, Nausea, Oropharyngeal pain
Clinical narrative: runny nose, cough, sore throat aches
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain, SARS-CoV-2 test positive
Clinical narrative: runny nose, cough, sore throat aches
Age: 21.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Cough, Oropharyngeal pain, Rhinorrhoea
Clinical narrative: runny nose, cough, sore throat aches
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 01/09/22 presents to EC ED for "generalized weakness/fatigue". PMHx of "PAF on Eliquis, CKD, HFrEF 35%, NICM s/p AICD (2009), T2DM, OSA, HLD and hypertension"
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Asthenia, Atrial fibrillation, COVID-19, Fatigue, SARS-CoV-2 test positive
Clinical narrative: 01/09/22 presents to EC ED for "generalized weakness/fatigue". PMHx of "PAF on Eliquis, CKD, HFrEF 35%, NICM s/p AICD (2009), T2DM, OSA, HLD and hypertension"
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthritis, Arthropathy, Joint noise, Myalgia, X-ray abnormal
Clinical narrative: Two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. It happens intermittently and is worse in the arm and elbow of the NON-injected; was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain; was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  An 81-year-old male patient received BNT162b2 (BNT162B2), on 05Jun2022 as dose 4 (booster), single (Lot number: FP4554) at the age of 81 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Shingles" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation. The following information was reported: ARTHROPATHY (non-serious) with onset 07Jun2022, outcome "not recovered", described as "Two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. It happens intermittently and is worse in the arm and elbow of the NON-injected"; MUSCLE STRAIN (non-serious), MYALGIA (non-serious) all with onset 07Jun2022, outcome "not recovered" and all described as "was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain". The events "two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. it happens intermittently and is worse in the arm and elbow of the non-injected" and "was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthropathy, muscle strain, myalgia.  Additional information: It was reported that joints in the body started clicking, popping, and snapping. It happened intermittently and was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain. Never had that happening before. The patient did not receive any other vaccine in four weeks of vaccination. The patient received other medications in two weeks of vaccination. The patient did not have COVID-19 prior to vaccination and was tested for COVID post vaccination. The patient had no known allergies. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment included Physical therapy.
Age: 81.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Arthropathy, Muscle strain, Myalgia, SARS-CoV-2 test
Clinical narrative: Two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. It happens intermittently and is worse in the arm and elbow of the NON-injected; was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain; was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  An 81-year-old male patient received BNT162b2 (BNT162B2), on 05Jun2022 as dose 4 (booster), single (Lot number: FP4554) at the age of 81 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Shingles" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Covid-19 vaccine (DOSE 1; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 2; MANUFACTURER UNKNOWN), for COVID-19 Immunisation; Covid-19 vaccine (DOSE 3 (BOOSTER); MANUFACTURER UNKNOWN), for COVID-19 Immunisation. The following information was reported: ARTHROPATHY (non-serious) with onset 07Jun2022, outcome "not recovered", described as "Two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. It happens intermittently and is worse in the arm and elbow of the NON-injected"; MUSCLE STRAIN (non-serious), MYALGIA (non-serious) all with onset 07Jun2022, outcome "not recovered" and all described as "was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain". The events "two (2) days after receiving my second booster (4th) shot the joints in my body started clicking, popping, and snapping. it happens intermittently and is worse in the arm and elbow of the non-injected" and "was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain" required physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of arthropathy, muscle strain, myalgia.  Additional information: It was reported that joints in the body started clicking, popping, and snapping. It happened intermittently and was worse in the arm and elbow of the non-injected arm, which may experience muscle strain and pain. Never had that happening before. The patient did not receive any other vaccine in four weeks of vaccination. The patient received other medications in two weeks of vaccination. The patient did not have COVID-19 prior to vaccination and was tested for COVID post vaccination. The patient had no known allergies. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Treatment included Physical therapy.
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: activity change, appetite change, unexpected weight change
Age: 81.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Appetite disorder, Dyskinesia, Weight abnormal
Clinical narrative: activity change, appetite change, unexpected weight change
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Fully vaccinated and boosted once.   COVID breakthrough infection
Age: 73.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Vaccine breakthrough infection
Clinical narrative: Fully vaccinated and boosted once.   COVID breakthrough infection
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: weakness
Age: 63.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia
Clinical narrative: weakness
Sex: M
Vaccine: MMRV
Symptoms: Product storage error
Clinical narrative: PROQUAD vaccine since excursion date on 7/14/2022; This spontaneous report has been received from a medical assistant concerning a 5-year-old male patient. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided.  On an unknown date in 2022, the patient was vaccinated with measles, mumps, rubella and varicella (oka-merck) virus vaccine live (recombinant human albumin) (PROQUAD) (rHA) subcutaneous injection, 0.5 milliliter (lot number W016358, expiration date 16-NOV-2023) as prophylaxis (strength, route of administration, vaccination scheme frequency, and anatomical location were not reported). According to temperature stability evaluation, the vaccine administered had been suffered a temperature excursion since 14-JUL-2022 (Product storage error).  This is one of ten reports received from the same reporter.; Sender's Comments:  US-009507513-2208USA004135: US-009507513-2208USA004105: US-009507513-2208USA003988: US-009507513-2208USA004086: US-009507513-2208USA003812: US-009507513-2208USA004011: US-009507513-2208USA004012: US-009507513-2208USA004060: US-009507513-2208USA004223:
Sex: U
Vaccine: HIBV
Symptoms: No adverse event, Product storage error
Clinical narrative: no adverse event; an imroperly stored dose of PEDVAX HIB was administered to a patient; This spontaneous report was received from a nurse referring to a patient of unknown age and gender. No information about the patient's pertinent medical history, concurrent conditions, concomitant medications, or drug reactions or allergies was provided.  On 08-AUG-2022, the patient started therapy with an improperly stored dose of haemophilus B conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) (lot #U026802, expiration date: 03-NOV-2023; strength, route of administration, vaccination scheme frequency, anatomical location, and dose were not reported) administered to prevent haemophilis influenza B infection (product storage error). No additional adverse event was reported (no adverse event).
Age: 13.0
Sex: U
Vaccine: MMRV
Symptoms: Expired product administered, No adverse event
Clinical narrative: No additional adverse event; A HCP called to report that an expired dose of PROQUAD was administered to a patient.; This spontaneous report has been received from a health care professional referring to a 13-year-old patient of unknown gender.  The patient's pertinent medical history, drugs reactions or allergies and concomitant medications were not provided.  On 09-AUG-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant Human albumin (rHA) (PROQUAD) subcutaneous injection, 0.5 milliliter, 1 dose, lot number U002531 has been verified to be a valid lot number with expiration date on 24-JUL-2022 (vaccination scheme, frequency, route of administration and anatomical site of injection were not provided); , and was reconstituted with sterile diluent (MRK) (strength, dose, units, vaccination scheme, frequency, route of administration, anatomical site of injection, lot number and expiration date were not provided), administered as prophylaxis. No additional adverse event was provided.   No additional adverse event (AE) was reported.
Sex: U
Vaccine: HEPA, HEPA, RV5
Symptoms: Product storage error
Clinical narrative: Inbound call from HCP stating that ROTATEQ and VAQTA may have been administered during and after a supported temp excursion.; No additional AE details; This spontaneous report was received from a medical assistant regarding an unknown number of patients of unknown age and gender. Their medical history, concurrent conditions and concomitant therapies were not reported.  On an unknown date, improperly stored vaccine doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) and hepatitis a vaccine, inactivated (VAQTA) underwent a temperature excursion of 50.2 degrees Fahrenheit (F) for about 8 hours and 30 minutes without previous excursions.  On a unknown date, the patients were vaccinated with improper storage doses of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #W011278, expiration date: 01-NOV-2023, lot #U037815, expiration date 28-MAY-2023, taken orally (dosage regimen, and route of administration were not provided) administered as prophylaxis; and hepatitis a vaccine, inactivated (VAQTA) lot #W002894, expiration date: 06-MAR-2023, lot #W006214, expiration date: 04-MAR-2023 (dosage regimen, anatomical location, and route of administration were not provided) administered as prophylaxis (Product storage error).   This is a non-valid report due to lack of patient's identifiers.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV9, HPV9
Symptoms: Arthralgia, Autonomic nervous system imbalance, Constipation, Cytogenetic analysis, Electrocardiogram
Clinical narrative: POTS; Dysautonomia; syncope; constipation; Arm/Shoulder/Joint pain; Sinus tachycardia; Information has been received from a consumer via the Administration (# 857405) on 17-AUG-2022, regarding a 14-year-old non-pregnant female patient (also reported as male, inconsistent information). The patient's concurrent conditions included asthma. Previous drug reactions, or allergies reported were bee venom (also reported as honey bee, inconsistent information) and strawberries.  On 03-FEB-2018 at 15:00 (also reported as 15:36, inconsistent information), the patient was vaccinated with hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) intramuscular (strength, dose, frequency, anatomical location, indication, lot number, and expiration date were not provided) indicated as prophylaxis. On the same fay, the patient was vaccinated with 1 dose of hepatitis A vaccine, inactivated (VAQTA)(also reported as hep a (HAVRIX), inconsistent information) intramuscular in the right arm (lot number N014945 has been verified to be a valid lot number, expiry date 17-JUN-2019) also indicated as prophylaxis.   On 06-MAR-2019 (also reported as 06-APR-2019, inconsistent information), the patient experienced POTS (postural orthostatic tachycardia syndrome), dysautonomia (autonomic nervous system imbalance), syncope, constipation, arm/shoulder/joint pain (arthralgia), and sinus tachycardia (hospitalization and disability criteria for ). Additional laboratory and diagnostical tests were performed: electrocardiogram (EKG), electroencephalogram (EEG), Holter Monitor 1 week; "Holter monitor" 30 days; medtronic LOOP monitor implant in chest wall; full laboratory panels, thyroid panels, genetics review and counseling to rule out potential for anything else that could have contributed.  The outcome of the aforementioned events was reported as not recovered.  The causality assessment was not provided.  Follow-up information has been received via telephone call to the physician office on 01-SEP-202 An unspecified reporter, stated that they could not help without a name and date of birth of the patient. The reporter was unable to find a healthcare provider who was completed the adverse event report. Additional information was not expected, all scheduled correspondence was canceled.
Age: 14.0
Sex: F
Vaccine: HEPA, HPV9, HPV9
Symptoms: Electrocardiogram ambulatory, Electroencephalogram, Implantable cardiac monitor insertion, Laboratory test, Pain in extremity
Clinical narrative: POTS; Dysautonomia; syncope; constipation; Arm/Shoulder/Joint pain; Sinus tachycardia; Information has been received from a consumer via the Administration (# 857405) on 17-AUG-2022, regarding a 14-year-old non-pregnant female patient (also reported as male, inconsistent information). The patient's concurrent conditions included asthma. Previous drug reactions, or allergies reported were bee venom (also reported as honey bee, inconsistent information) and strawberries.  On 03-FEB-2018 at 15:00 (also reported as 15:36, inconsistent information), the patient was vaccinated with hpv rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) intramuscular (strength, dose, frequency, anatomical location, indication, lot number, and expiration date were not provided) indicated as prophylaxis. On the same fay, the patient was vaccinated with 1 dose of hepatitis A vaccine, inactivated (VAQTA)(also reported as hep a (HAVRIX), inconsistent information) intramuscular in the right arm (lot number N014945 has been verified to be a valid lot number, expiry date 17-JUN-2019) also indicated as prophylaxis.   On 06-MAR-2019 (also reported as 06-APR-2019, inconsistent information), the patient experienced POTS (postural orthostatic tachycardia syndrome), dysautonomia (autonomic nervous system imbalance), syncope, constipation, arm/shoulder/joint pain (arthralgia), and sinus tachycardia (hospitalization and disability criteria for ). Additional laboratory and diagnostical tests were performed: electrocardiogram (EKG), electroencephalogram (EEG), Holter Monitor 1 week; "Holter monitor" 30 days; medtronic LOOP monitor implant in chest wall; full laboratory panels, thyroid panels, genetics review and counseling to rule out potential for anything else that could have contributed.  The outcome of the aforementioned events was reported as not recovered.  The causality assessment was not provided.  Follow-up information has been received via telephone call to the physician office on 01-SEP-202 An unspecified reporter, stated that they could not help without a name and date of birth of the patient. The reporter was unable to find a healthcare provider who was completed the adverse event report. Additional information was not expected, all scheduled correspondence was canceled.